Skip to Main Content
Samer Zaid Kaylani, M.D.

Samer Zaid Kaylani, M.D.

Clinical Associate Professor

School
Medical School
Department
Pediatrics

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Download Curriculum Vitae

    Samer Zaid Kaylani, M.D., FAAP,  is a Clinical Associate Professor in the Department of Pediatrics at UT Southwestern Medical Center. He specializes in Pediatric Hematological Disorders including Sickle Cell disease, Chronic transfusion medicine, Bleeding/Clotting Disorders and different types of Pancytopenias.

    Dr. Zaid Kaylani earned his medical degree at Jordan University of Science and Technology. He completed his residency in pediatrics at the Texas Tech University in Amarillo, and gained advanced training in pediatric hematology and oncology through a fellowship at University of Alabama in Birmingham.

    Certified by the American Board of Pediatrics in pediatric hematology and oncology in 2015.

    He initialy joined the faculty at Lousisana State University in 2013 and worked at the St Jude Affliate clinic in Shreveport. He then Joined the faculty at Texas Tech University in Amarillo in 2017. He was the acting Program Director for the residency program starting in 2019.  He was the Primary Prinicipal Investigator for Children Oncology Group in Amarillo, having revived the program in 2019. He joined the UT Southwestern faculty in 2023.

    He is a member of the American Society of Pediatric Hematology/Oncology and the American Society of Hematology.

    Dr. Zaid Kaylani has delivered numerous lectures to residents and medical students, and published numerous academic articles, case reports and poster presentations related to his areas of expertise.He has been awarded numerous awards for his teaching and patient care. 

    Personal Note

    Outside of work, Dr. Zaid Kaylani enjoys playing the piano, gardening, spending time with his family, and driving his children to activities.

  • Education
    Medical School
    Jordan University of Science and Technology Faculty of Medicine, Jordan (2006)
    Residency
    Texas Tech Health Sciences Center in Amarillo (2010), Pediatrics
    Fellowship
    University of Alabama at Birmingham (2013), Pediatric Hematology/oncology
  • Research Interest
    • Chronic Transfusion Medicine
    • Sickle cell disease
  • Publications

    Star Featured Publications

    Head Lice Infestation: An Unusual Cause of Iron Deficiency Anemia in a 13-Year-Old Female.
    Ogbuji CO, Schuck A, DeVries M, Majdinasab EJ, Benson K, Zaid-Kaylani S, Bhaskaran S, Cureus 2022 Jun 14 6 e25956
    REFRACTORY IMMUNE THROMBOCYTOPENIA WITH SUSPECTED EVANS SYNDROME REQUIRING QUADRUPLE THERAPY
    Bewaji O, Kandaswamy , Maniam G , Bhaskaran S , Zaid-Kaylani S Journal of Rare Diseases and Orphan Drugs, V1, 2020 2020
    National Trends in Hospitalization for Fever and Neutropenia in Children with Cancer, 2007-2014.
    Lekshminarayanan A, Bhatt P, Linga VG, Chaudhari R, Zhu B, Dave M, Donda K, Savani S, Patel SV, Billimoria ZC, Bhaskaran S, Zaid-Kaylani S, Dapaah-Siakwan F, Bhatt NS, J Pediatr 2018 Nov 202 231-237.e3
    Temporal trends of splenectomy in pediatric hospitalizations with immune thrombocytopenia.
    Bhatt NS, Bhatt P, Donda K, Dapaah-Siakwan F, Chaudhari R, Linga VG, Patel B, Lekshminarayanan A, Bhaskaran S, Zaid-Kaylani S, Badawy SM, Pediatr Blood Cancer 2018 Jul 65 7 e27072
    A 14-year-old boy with extranodal natural killer cell lymphoma of the nose, nasopharynx, larynx, and trachea in remission 6years after primary diagnosis. A longitudinal case report.
    Gungor A, Pennington L, Sankararaman S, Zaid-Kaylani S, Jeroudi MA, Am J Otolaryngol 2016 37 6 563-566
    GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis.
    Srivastava RK, Kaylani SZ, Edrees N, Li C, Talwelkar SS, Xu J, Palle K, Pressey JG, Athar M Oncotarget 2014 Oct
    Rapamycin targeting mTOR and hedgehog signaling pathways blocks human rhabdomyosarcoma growth in xenograft murine model.
    Kaylani SZ, Xu J, Srivastava RK, Kopelovich L, Pressey JG, Athar M, Biochem Biophys Res Commun 2013 Jun 435 4 557-61
    Treatment of infantile hemangiomas with sirolimus in a patient with PHACE syndrome.
    Kaylani S, Theos AJ, Pressey JG, Pediatr Dermatol 2013 30 6 e194-7
  • Honors & Awards
    • Texas Tech Unsung Hero Award
      Regional Dean Award-Texas Tech University Dean (2022)
    • Texan Taking Care of Texans Award
      Texas State Department (2021)
    • Golden Humanism Honor Award
      Gold Humanism Honor Society NW Texas Chapter (2019)
    • Resident Choice Award
      Texas Tech Pediatrics Department (2019)
    • Teaching Faculty Award
      Texas Tech Deans Award (2019)
    • John R.Durant Award Excellence in Cancer Research
      University of Alabama at Birmingham (2012)
    • Service Excellence Award
      Northwest Texas Hospital (2008)
    • Medical School Honor List
      Jordan University of Science and Technology (2000-2006)
  • Professional Associations/Affiliations
    • American Academy of Clinical Research (2012-2013)
    • American Academy of Pediatrics (2010)
    • American Society of Clinical Oncology (2010-2012)
    • American Society of Hematology (ASH) (2010)
    • American Society of Pediatric Hematology Oncology (2010)
    • Children Oncology Group (2019-2022)
    • Dallas County Medical Society (2023)
    • Jordan Medical Association (2007)
    • Texas Medical Association (2023)